•
Sep 30, 2023

Inozyme Q3 2023 Earnings Report

Total Revenue
$0
EPS
-$0.29
Previous year: -$0.38
-23.7%
Gross Profit
-$333K
Cash and Equivalents
$192M
Previous year: $142M
+36.0%
Free Cash Flow
-$18.9M
Previous year: -$14.7M
+28.7%
Total Assets
$206M
Previous year: $154M
+33.6%

Inozyme

Inozyme